NICE Gives Nod to HeartFlow’s Cardiac Imaging Platform

The UK’s price watchdog is backing coverage for HeartFlow’s cardiac imaging platform, which is intended to treat patients with onset chest pain of suspected cardiac origin and a risk for coronary artery disease.

UK’s National Institute of Health and Care Excellence found the device to be cost and clinically effective, noting its diagnostic accuracy and capacity to save patients money on costlier procedures.

HeartFlow uses standard coronary computed tomography angiography image data to estimate fractional flow reserve. — José Vasquez